Phase II study of D-verapamil and doxorubicin in patients with metastatic colorectal cancer.
Scheithauer
W
W
Kornek
G
G
Kastner
J
J
Raderer
M
M
Locker
G
G
Depisch
D
D
Pidlich
J
J
Tetzner
C
C
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D016896:Treatment Outcome; D014700:Verapamil / Q000008:administration & dosage
D004317:Doxorubicin; D014700:Verapamil